Güngör Olcay, Özkaya Ahmet Kağan, Güngör Gülay, Karaer Kadri, Dilber Cengiz, Aydin Kürşad
Department of Pediatric Neurology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
Department of Pediatric Emergency, Faculty of Medicine, Cukurova University, Adana, Turkey.
Pediatr Int. 2016 Jul;58(7):659-61. doi: 10.1111/ped.12921. Epub 2016 Mar 8.
Succinate-CoA ligase, ADP-forming, beta subunit (SUCLA2)-related mitochondrial DNA depletion syndrome is caused by mutations affecting the ADP-using isoform of the beta subunit in succinyl-CoA synthase, which is involved in the Krebs cycle. The SUCLA2 protein is found mostly in heart, skeletal muscle, and brain tissues. SUCLA2 mutations result in a mitochondrial disorder that manifests as deafness, lesions in the basal ganglia, and encephalomyopathy accompanied by dystonia. Such mutations are generally associated with mildly increased plasma methylmalonic acid, increased plasma lactate, elevated plasma carnitine esters, and the presence of methylmalonic acid in urine. In this case report, we describe a new mutation in a patient with a succinyl-CoA synthase deficiency caused by an SUCLA2 defect.
琥珀酰辅酶A连接酶(ADP形成)β亚基(SUCLA2)相关的线粒体DNA耗竭综合征是由影响琥珀酰辅酶A合成酶β亚基ADP利用同工型的突变引起的,该酶参与三羧酸循环。SUCLA2蛋白主要存在于心脏、骨骼肌和脑组织中。SUCLA2突变导致线粒体疾病,表现为耳聋、基底神经节病变和伴有肌张力障碍的脑肌病。此类突变通常与血浆甲基丙二酸轻度升高、血浆乳酸增加、血浆肉碱酯升高以及尿中甲基丙二酸的存在有关。在本病例报告中,我们描述了一名因SUCLA2缺陷导致琥珀酰辅酶A合成酶缺乏患者的新突变。